| N |
Investment project title |
"Dermafen" remedy as a potential drug for burn wound healing |
| 1. |
Sector |
Drug manufacturing |
| 2. |
Project description |
The aim is to develop an effective burn healing drug in a form of ointment and cream. It may also be used for cutaneous wound treatment with different etiology. "Dermafen" possesses a wide range of actions and demonstrates prominent clinical effect. |
| 3. |
Project implementation period |
2-3 years |
| 4. |
Project location |
Scientific and Technological Centre of Organic and Pharmaceutical Chemistry of NAS RA |
| 5. |
Project overall cost (USD) |
102.000 |
| 6. |
Required investments (USD) |
102.000 |
| 7. |
Own funds (USD) |
- |
| 8. |
Creation of jobs |
At the beginning of the project |
At the end of the project |
| 10 |
3 |
| 9. |
Payback period |
5-6 years |
| 10. |
Annual profitability index |
1.5 million AMD (USD 3.125) |
| 11. |
Detailed costs |
1. Drug preclinical trial - 12 million AMD
2. Drug clinical trial - 20 million AMD
3. Purchase of modern equipment and reagents - 10 million AMD
4. Synthesis of 2 kg drug raw material and drug production - 3.5 million AMD
5. Purchase of benzocaine and other compounds - 0.5 million AMD
6. Preparing of drug formulary and registration in RA - 3 million AMD
Total - 49 million AMD (USD 102.085) |
| 12. |
Offer to investor |
- |
| 13. |
Contact details |
Vigen Topuzyan, Director of the Scientific and Technological Center of Organic and Pharmaceutical Chemistry of NAS RA
E-mail: vtop {[ at ]} web.am
Tel.: (+374 10) 288334 |
![academy [@] sci.am](images/email.jpg "academy [@] sci.am")
